PATENT CLAIM ANALYSIS

Application Number: 16392004
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["424", "135100"]

Abstract:
The present application describes an antibody-coding, non-modified or modified RNA and the use thereof for expression of this antibody, for the preparation of a pharmaceutical composition, in particular a passive vaccine, for treatment of tumours and cancer diseases, cardiovascular diseases, infectious diseases, autoimmune diseases, virus diseases and monogenetic diseases, e.g. also in gene therapy. The present invention furthermore describes an in vitro transcription method, in vitro methods for expression of this antibody using the RNA according to the invention and an in vivo method.

Claim (Index 3):
The method of  claim 1 , wherein the pharmaceutical composition is administered by injection.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 100.0
- Lexical Diversity: 1.86538
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15899326', '15233933', '14378606', '12994407', '13750664']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533854475104067
- 35 USC 102 Novelty (BERT): 0.5317346820766033
- Combined Prediction Score: 0.7312203709670264
- Mean Citation Score: 304.697522
- Max Citation Score: 349.9688
- Similarity Product: 238.2432048970699

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test